US FDA Would See Another Austere Year With GOP Funding Bill, No PRV Reauthorization

US Capitol building
The Republican funding bill released 8 March, if enacted, would once again give the FDA no boost in taxpayer funding. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Rare Diseases